Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Insulet Corporation PODD
$328.37
+$7.26 (2.21%)
На 18:00, 12 мая 2023
-5.72%
Потенциал через год
Ранг: 1
Ключевые показатели
-
Marketcap
22302656000.00000000
-
week52high
335.91
-
week52low
181.00
-
Revenue
1305300000
-
P/E TTM
4965
-
Beta
0.79100300
-
EPS
0.06000000
-
Last Dividend
0.00000000
-
Next Earnings Date
04 мая 2023 г. в 20:00
Описание компании
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Equal-Weight | Equal-Weight | 08 авг 2022 г. |
| Raymond James | Outperform | Outperform | 05 авг 2022 г. |
| Piper Sandler | Neutral | Neutral | 05 авг 2022 г. |
| Canaccord Genuity | Buy | Buy | 05 авг 2022 г. |
| Baird | Outperform | Outperform | 05 авг 2022 г. |
| Barclays | Equal-Weight | 18 окт 2022 г. | |
| Jefferies | Hold | 12 окт 2022 г. | |
| Raymond James | Outperform | Outperform | 04 ноя 2022 г. |
| Piper Sandler | Overweight | Neutral | 04 ноя 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 04 ноя 2022 г. |
| Baird | Outperform | Outperform | 04 ноя 2022 г. |
| Morgan Stanley | Equal-Weight | Equal-Weight | 06 янв 2023 г. |
| Wolfe Research | Peer Perform | 26 янв 2023 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Покожие компании
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Petrovic Shacey | D | 11838 | 4555 | 04 янв 2023 г. |
| Petrovic Shacey | D | 0 | 10445 | 04 янв 2023 г. |
| Petrovic Shacey | D | 14789 | 15000 | 04 янв 2023 г. |
| Petrovic Shacey | A | 29789 | 4555 | 04 янв 2023 г. |
| Petrovic Shacey | A | 25234 | 10445 | 04 янв 2023 г. |
| McMillan Wayde D. | D | 19995 | 1359 | 03 янв 2023 г. |
| Petrovic Shacey | D | 16393 | 1094 | 16 дек 2022 г. |
| Petrovic Shacey | A | 14789 | 1094 | 16 дек 2022 г. |
| Petrovic Shacey | A | 73205 | 22887 | 15 дек 2022 г. |
| Petrovic Shacey | D | 0 | 22887 | 15 дек 2022 г. |
Новостная лента
3 Top Stocks to Buy Now for Stellar Earnings Growth
Zacks Investment Research
09 мая 2023 г. в 08:24
Stocks such as Franklin Electric (FELE), Insulet (PODD) & Wingstop (WING) have striking earnings growth and positive estimate revisions.
New Highs: Diabetes Stock Breaks Out. Cement Maker Surges Past Buy Point.
Investors Business Daily
05 мая 2023 г. в 14:34
PODD stock hit new highs in March when it joined the S&P 500. Now, shares are breaking out.
Insulet (PODD) Q1 Earnings Beat Estimates, Sales View Up
Zacks Investment Research
05 мая 2023 г. в 14:27
Omnipod 5 continues to be a driving force of Insulet's (PODD) strong U.S. growth, representing almost 95% of U.S. new customer starts in the first quarter.
Insulet (PODD) Q1 Earnings and Revenues Top Estimates
Zacks Investment Research
04 мая 2023 г. в 19:01
Insulet (PODD) came out with quarterly earnings of $0.23 per share, beating the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.40 per share a year ago.
Buy These 5 Stocks Ahead of Earnings Releases This Week
Zacks Investment Research
04 мая 2023 г. в 06:53
We have narrowed our search to five stocks that are set to report earnings results this week. These are: PODD, BKNG, BILL, JCI and COLD.